A twice-a-year shot for HIV prevention could make it easier for people to protect themselves from the virus, argues an executive from Gilead Sciences, which developed the drug.
“You can go to your doctor, go behind a closed door, get the injection, walk out of the closed door, and no one knows why you were there," said Jared Baeten, the company’s senior vice president and virology therapeutic area head.
"No one knows that you have been there, and you don't have to think about it again until six months from now.”
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.